Modeling β-Cell Insulin Secretion - Implications for Closed-Loop Glucose Homeostasis
- 1 December 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 5 (6) , 953-964
- https://doi.org/10.1089/152091503322640999
Abstract
Glucose sensing and insulin delivery technology can potentially be linked to form a closed-loop insulin delivery system. Ideally, such a system would establish normal physiologic glucose profiles. To this end, a model of β-cell secretion can potentially provide insight into the preferred structure of the insulin delivery algorithm. Two secretion models were evaluated for their ability to describe plasma insulin dynamics during hyperglycemic clamps (humans; n = 7), and for their ability to establish and maintain fasting euglycemia under conditions simulated by the minimal model. The first β-cell model (SD) characterized insulin secretion as a static component that had a delayed response to glucose, and a dynamic component that responded to the rate of increase of glucose. The second model (PID) described the response in terms of a proportional component without delay, an integral component that adjusted basal delivery in proportion to hyper/hypoglycemia, and a derivative component that responded to the rate of glucose change. Both models fit the β-cell response during the clamp, and established fasting euglycemia under simulated closed-loop conditions; however, the SD model did not maintain euglycemia following simulated changes in insulin sensitivity or glucose appearance, whereas the PID model did. The PID model was more stable under the simulated closed-loop conditions. Both the SD and PID models described β-cell secretion in response to a rapid increase in glucose. However, the PID model could maintain fasting euglycemia and was more stable under closed-loop conditions, and thus is more suited for such conditions.Keywords
This publication has 28 references indexed in Scilit:
- Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home UseDiabetes Technology & Therapeutics, 2000
- Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot studyDiabetes Research and Clinical Practice, 1999
- Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDMDiabetologia, 1998
- Insulin lispro in CSII: results of a double-blind crossover studyDiabetes, 1997
- Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDMDiabetes, 1994
- Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.Journal of Clinical Investigation, 1989
- Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptakeMetabolism, 1989
- Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic eventsDiabetes, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Effect of Differences in Glucose Tolerance on Insulin's Ability to Regulate Carbohydrate and Free Fatty Acid Metabolism in Obese Individuals*Journal of Clinical Endocrinology & Metabolism, 1986